Skip to content

Oxygen-Amplified Carrier-Free Nanomedicine Integrating Ferroptosis/Photodynamic Therapy and COX-2/PGE2 Blockade for Robust Antitumor Immunity Against Glioma.

Oct 2026 · ACS Applied Materials and Interfaces · 0 citations · 46 references
Medicine

TL;DR

An oxygen‑amplified carrier‑free nanomedicine (IHC NPs) through hydrophobic self‑assembly of IR-820, hemin, and celecoxib is developed that provides a promising oxygen‑amplified carrier‑free nanomedicine for robust glioma immunotherapy.

Abstract

The therapeutic efficacy of glioma immunotherapy is severely hampered by immunosuppression in the tumor microenvironment. Here, we develop an oxygen‑amplified carrier‑free nanomedicine (IHC NPs) through hydrophobic self‑assembly of IR-820, hemin, and celecoxib. IHC NPs exhibit excellent stability, biological safety, and preferential tumor accumulation. In the subcutaneous glioma model, the combination of IHC NPs and αPD-L1 significantly inhibited subcutaneous tumor growth and effectively prevented distant tumor metastasis. Mechanistically, hemin catalyzes endogenous H2O2 to generate oxygen, thereby alleviating tumor hypoxia. This oxygen boost potentiates IR-820‑mediated photodynamic therapy and hemin-based ferroptosis, enhancing direct tumor cell killing. Concurrently, celecoxib blocks the COX‑2/PGE2 pathway, reversing immunosuppression within the tumor microenvironment. Through the synergistic strategy combining oxygen-sensitized photodynamic therapy, ferroptosis, COX-2/PGE2 suppression, and PD-1/PD-L1 blockade, this therapeutic regimen effectively induces tumor immunogenic cell death, promotes dendritic cell maturation, enhances intratumoral infiltration of cytotoxic T lymphocytes, reduces the abundance of regulatory T cells, and triggers the generation of effector memory T cells, thereby potently activating the host immune system. Collectively, our work provides a promising oxygen‑amplified carrier‑free nanomedicine for robust glioma immunotherapy.

View source

Similar papers

Sep 2026

Enzyme-like bimetallic nanoclusters modulate tumor microenvironment to enhance radiosensitization for multimodal imaging and synergistic photothermal-radiotherapy.

This TME-responsive bimetallic nanoplatform successfully integrates radiosensitization, multimodal imaging, and PTT, offering a robust strategy for imaging-guided precision cancer therapy.

Rui-Ying Zhang, Miao-Qing Li, Rui Cao et al. · 0 citations
Open access Oct 2026

Tumor Microenvironment-Triggered Dual-Prodrug Nanoplatform for Augmented Photodynamic Therapy: Self-Quenched Photosensitizer Activation and Nitric Oxide-Mediated Sensitization

Photodynamic therapy (PDT) holds great promise for cancer treatment owing to its spatiotemporal selectivity and minimal invasiveness. However, its therapeutic efficacy is hampered by photosensitizer self-quenching and intrinsic tumor hypoxia. Herein, we construct a tumor-microenvironment (TME)-activated dual-prodrug na...

Yuxuan Gu, Jia-Qi Ding, Jia-Li Zhang et al. · 0 citations
Open access Oct 2026

Supramolecular self-assembled nanomedicine targeting fatty acid metabolism to potentiate ferroptosis-enhanced photoimmunotherapy in triple-negative breast cancer

Triple-negative breast cancer (TNBC) presents a serious therapeutic challenge, largely owing to its metabolic adaptability and the immunosuppressive nature of its tumor microenvironment (TME). Photodynamic therapy (PDT) can cause oxidative injury and induce immunogenic cell death (ICD); however, its antitumor activity...

Fei Li, Jun-Yong Wu, Xin-Yan Hao et al. · 0 citations
Sep 2026

An Immunogenic Cell Death-Enhanced Self-Assembled Nanoparticle-Composite Hydrogel for Postoperative Local Immunotherapy of Melanoma.

Photodynamic therapy (PDT) can elicit antitumor immunity by inducing immunogenic cell death (ICD), making it an attractive option for postoperative local cancer treatment. However, in solid tumors, aberrant vasculature and an immunosuppressive microenvironment often restrict immune-cell infiltration, thereby weakening...

Wei-Li Zhou, Deng-Ming Zhou, Haroon Iqbal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.